Single-point plasma or urine dextromethorphan method for determining CYP3A activity
- 25 September 2003
- journal article
- clinical trial
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 24 (9) , 367-373
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CYP3A4 drug interactions: correlation of 10 in vitro probe substratesBritish Journal of Clinical Pharmacology, 1999
- Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activityJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activityJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Noninvasive tests of CYP3A enzymesPharmacogenetics, 1994
- Characterization of dextromethorphan N-demethylation by human liver microsomesBiochemical Pharmacology, 1994
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Salivary analysis for determination of dextromethorphan metabolic phenotypeClinical Pharmacology & Therapeutics, 1991
- Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.Journal of Clinical Investigation, 1989